{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:16:18Z","timestamp":1772770578205,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s11046-024-00859-w","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T10:02:07Z","timestamp":1718186527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis\u2013An Exploratory Study"],"prefix":"10.1007","volume":"189","author":[{"given":"Himanshu","family":"Dandu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1316-8702","authenticated-orcid":false,"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hardeep Singh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vipin Raj","family":"Bharti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geeta","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerendra","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"4","key":"859_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jobcr.2021.08.001","volume":"11","author":"HS Malhotra","year":"2021","unstructured":"Malhotra HS, Gupta P, Mehrotra D, Dandu H, Kohli N, Verma V, Kaur A, Kumar N, Prabhu V, Singh MK, Jaiswal R. COVID-19 associated mucormycosis: staging and management recommendations (Report of a multi-disciplinary expert committee). J Oral Biol Craniofac Res. 2021;11(4):569\u201380. https:\/\/doi.org\/10.1016\/j.jobcr.2021.08.001.","journal-title":"J Oral Biol Craniofac Res"},{"issue":"3","key":"859_CR2","doi-asserted-by":"publisher","first-page":"101007","DOI":"10.1016\/j.mycmed.2020.101007","volume":"30","author":"K Brunet","year":"2020","unstructured":"Brunet K, Rammaert B. Mucormycosis treatment: recommendations, latest advances, and perspectives. J de mycologie med. 2020;30(3):101007. https:\/\/doi.org\/10.1016\/j.mycmed.2020.101007.","journal-title":"J de mycologie med"},{"issue":"12","key":"859_CR3","doi-asserted-by":"publisher","first-page":"1049959","DOI":"10.3389\/fcimb.2022.1049959","volume":"1","author":"T Zhang","year":"2022","unstructured":"Zhang T, Shen Y, Feng S. Clinical research advances of isavuconazole in the treatment of invasive fungal diseases. Front Cell Infect Microbiol. 2022;1(12):1049959. https:\/\/doi.org\/10.3389\/fcimb.2022.1049959.","journal-title":"Front Cell Infect Microbiol"},{"key":"859_CR4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s40265-016-0652-6","volume":"76","author":"M Shirley","year":"2016","unstructured":"Shirley M, Scott LJ. Isavuconazole: a review in invasive aspergillosis and mucormycosis. Drugs. 2016;76:1647\u201357. https:\/\/doi.org\/10.1007\/s40265-016-0652-6.","journal-title":"Drugs"},{"key":"859_CR5","doi-asserted-by":"publisher","first-page":"e23417","DOI":"10.1002\/jbt.23417","volume":"22","author":"HS Chaudhari","year":"2023","unstructured":"Chaudhari HS, Palkar OS, Abha Mishra KM, Sethi KK. An extensive review on antifungal approaches in the treatment of mucormycosis. J Biochem Mol Toxicol. 2023;22:e23417. https:\/\/doi.org\/10.1002\/jbt.23417.","journal-title":"J Biochem Mol Toxicol"},{"issue":"7","key":"859_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/14787210.2023.2224564","volume":"21","author":"JP Lynch III","year":"2023","unstructured":"Lynch JP III, Zhanel GG. Part 2: Mucormycosis: focus on therapy. Expert Rev Anti Infect Ther. 2023;21(7):737\u201348. https:\/\/doi.org\/10.1080\/14787210.2023.2224564.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"859_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2217\/fmb-2016-0231","volume":"12","author":"E Bagshaw","year":"2017","unstructured":"Bagshaw E, Kuessner D, Posthumus J, Escrig C, Blackney M, Heimann SM, Cornely OA. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK. Future Microbiol. 2017;12(6):515\u201325. https:\/\/doi.org\/10.2217\/fmb-2016-0231.","journal-title":"Future Microbiol"},{"key":"859_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","volume":"45","author":"R Bellmann","year":"2017","unstructured":"Bellmann R, Smuszkiewicz P. Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients. Infection. 2017;45:737\u201379. https:\/\/doi.org\/10.1007\/s15010-017-1042-z.","journal-title":"Infection"},{"issue":"7\u20138","key":"859_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1439-0507.1993.tb00755.x","volume":"36","author":"G Cauwenbergh","year":"1993","unstructured":"Cauwenbergh G. Cryptococcal meningitis: the place of itraconazole. Mycoses. 1993;36(7\u20138):221\u20138. https:\/\/doi.org\/10.1111\/j.1439-0507.1993.tb00755.x.","journal-title":"Mycoses"},{"issue":"3\u20134","key":"859_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1439-0507.2004.00959.x","volume":"47","author":"DP Eisen","year":"2004","unstructured":"Eisen DP, Robson J. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis. Mycoses. 2004;47(3\u20134):159\u201362. https:\/\/doi.org\/10.1111\/j.1439-0507.2004.00959.x.","journal-title":"Mycoses"},{"issue":"4","key":"859_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1179\/146532808X375477","volume":"28","author":"R Ganesh","year":"2008","unstructured":"Ganesh R, Manikumar S, Vasanthi T. Rhinocerebral mucormycosis in an adolescent with type 1 diabetes mellitus: case report. Ann Trop Paediatr. 2008;28(4):297\u2013300. https:\/\/doi.org\/10.1179\/146532808X375477.","journal-title":"Ann Trop Paediatr"},{"issue":"1\u20132","key":"859_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1439-0507.1998.tb00376.x","volume":"41","author":"K Parthiban","year":"1998","unstructured":"Parthiban K, Gnanaguruvelan S, Janaki C, Sentamilselvi G, Boopalraj JM. Rhinocerebral zygomycosis: Rhinozerebrale zygomykose. Mycoses. 1998;41(1\u20132):51\u20133. https:\/\/doi.org\/10.1111\/j.1439-0507.1998.tb00376.x.","journal-title":"Mycoses"},{"key":"859_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-016-0189-1","volume":"16","author":"N Jiang","year":"2016","unstructured":"Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, Wang Q, Xu Q. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. BMC Ophthalmol. 2016;16:1\u20137. https:\/\/doi.org\/10.1186\/s12886-016-0189-1.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"859_CR14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/jim-2021-002179","volume":"70","author":"P Gupta","year":"2022","unstructured":"Gupta P, Malhotra HS, Saxena P, Singh R, Shukla D, Hasan MS, Verma V, Banerjee G, Puri B, Dandu H. Utility of itraconazole and terbinafine in mucormycosis: a proof-of-concept analysis. J Investig Med. 2022;70(4):914\u20138. https:\/\/doi.org\/10.1136\/jim-2021-002179.","journal-title":"J Investig Med"},{"key":"859_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1439-0507.1989.tb02296.x","volume":"32","author":"J Heykants","year":"1989","unstructured":"Heykants J, Van Peer A, Van de Velde V, Van Rooy P, Meuldermans W, Lavrijsen K, Woestenborghs R, Van Cutsem J, Cauwenbergh G. The clinical pharmacokinetics of itraconazole: an overview. Mycoses. 1989;32:67\u201387. https:\/\/doi.org\/10.1111\/j.1439-0507.1989.tb02296.x.","journal-title":"Mycoses"},{"issue":"10","key":"859_CR16","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/archinte.1989.00390100107024","volume":"149","author":"DW Denning","year":"1989","unstructured":"Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med. 1989;149(10):2301\u20138.","journal-title":"Arch Intern Med"},{"issue":"8","key":"859_CR17","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1128\/JCM.41.8.3623-3626.2003","volume":"41","author":"DJ Diekema","year":"2003","unstructured":"Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol. 2003;41(8):3623\u20136. https:\/\/doi.org\/10.1128\/JCM.41.8.3623-3626.2003.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"859_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1128\/AAC.46.4.1032-1037.2002","volume":"46","author":"MA Pfaller","year":"2002","unstructured":"Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial surveillance program, 2000. Antimicrob agents chemother. 2002;46(4):1032\u20137. https:\/\/doi.org\/10.1128\/AAC.46.4.1032-1037.2002.","journal-title":"Antimicrob agents chemother"},{"issue":"7","key":"859_CR19","doi-asserted-by":"publisher","first-page":"myad067","DOI":"10.1093\/mmy\/myad067","volume":"61","author":"J Taneja","year":"2023","unstructured":"Taneja J, Chatterjee K, Sasidharan J, Abbas SZ, Rai AK, Raychaudhury S, Das B, Das A. Post-COVID-19 rhino-orbito-cerebral mucormycosis\u2013A clinico-mycological study from North India. Med Mycol. 2023;61(7):myad067. https:\/\/doi.org\/10.1093\/mmy\/myad067.","journal-title":"Med Mycol"},{"key":"859_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35814","author":"CY Cham","year":"2023","unstructured":"Cham CY, Radhakrishnan AP, Chang CY. Successful treatment of mucormycosis caused by Rhizopus arrhizus with amphotericin B and itraconazole. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.35814.","journal-title":"Cureus"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-024-00859-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-024-00859-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:15:27Z","timestamp":1724415327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-024-00859-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1007\/s11046-024-00859-w","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"3 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The authors confirm that the ethical policies of the journal, as noted on the journal\u2019s author guidelines page, have been adhered to and the appropriate ethical review committee approval has been received.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"Written consent was obtained from patients\/relatives before enrolment in the present study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publications"}}],"article-number":"54"}}